Auxiliary diagnosis of Lung Cancer on the basis of a Serum Protein Biomarker Panel

Conclusions: It was demonstrated that 4-protein biomarker panel had a significant performance in identifying lung cancer patients from healthy controls, especially combining with the nodule size. Specifically, it yielded excellent discrimination for identifying early-stage lung cancer patients than individual biomarker alone. A future large-scale study is underway to further define the clinical application of this method for the early diagnosis of lung cancer among Chinese populations.

Source: Journal of Cancer - April 19, 2021 Category: Cancer & Oncology Authors: Qiong Lu, Zhongwei Jia, Junli Gao, Meijuan Zheng, Junshun Gao, Mingjie Tong, Jinxing Xia, Fang Li, Baoling Yang, Lili Zhang, Bo Wang, Rui Wang, Jinping Qiao, Qinqin Lou, Jinbo Gao, Yuanhong Xu Tags: Research Paper Source Type: research